药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rescinnamine
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Panobinostat.
Rescinnamine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Panobinostat.
Rescinnamine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Panobinostat.
Rescinnamine
Idelalisib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Panobinostat.
Rescinnamine
Siponimod
The risk or severity of adverse effects can be increased when Panobinostat is combined with Siponimod.
Rescinnamine
Bleselumab
The risk or severity of adverse effects can be increased when Panobinostat is combined with Bleselumab.
Rescinnamine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Panobinostat is combined with Rozanolixizumab.
Rescinnamine
Risankizumab
The risk or severity of adverse effects can be increased when Panobinostat is combined with Risankizumab.
Rescinnamine
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Panobinostat is combined with Monomethyl fumarate.
Rescinnamine
Tetrandrine
The risk or severity of adverse effects can be increased when Panobinostat is combined with Tetrandrine.
Rescinnamine
Fluclorolone
The risk or severity of adverse effects can be increased when Panobinostat is combined with Fluclorolone.
Rescinnamine
Fluperolone
The risk or severity of adverse effects can be increased when Panobinostat is combined with Fluperolone.
Rescinnamine
Begelomab
The risk or severity of adverse effects can be increased when Panobinostat is combined with Begelomab.
Rescinnamine
Fluocortin
The risk or severity of adverse effects can be increased when Panobinostat is combined with Fluocortin.
Rescinnamine
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Panobinostat is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Rescinnamine
Hypericin
The risk or severity of adverse effects can be increased when Panobinostat is combined with Hypericin.
Rescinnamine
Acteoside
The risk or severity of adverse effects can be increased when Panobinostat is combined with Acteoside.
Rescinnamine
Deoxyspergualin
The risk or severity of adverse effects can be increased when Panobinostat is combined with Deoxyspergualin.
Rescinnamine
Doxifluridine
The risk or severity of adverse effects can be increased when Panobinostat is combined with Doxifluridine.
Rescinnamine
Trofosfamide
The risk or severity of adverse effects can be increased when Panobinostat is combined with Trofosfamide.